PDGFRB and neoplasm: To address this possibility, we initially investigated the pericyte coverage of blood vessels using two different methods, measurement of α-SMA staining (colocalized with VE-cadherin) of tumor sections (Fig. 5A–C) and analysis of tumors for the pericyte marker PDGFRβ by Western blot (Fig. 5D, E).